Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:53 PM
Ignite Modification Date: 2025-12-25 @ 2:36 PM
NCT ID: NCT02053350
Description: All AEs including local and systemic reactions not meeting the criteria for "serious adverse events" will be captured on the appropriate CRF. Information to be collected includes event description, time of onset, clinician's assessment of severity, relationship to study product
Frequency Threshold: 0
Time Frame: 6 months post randomization.
Study: NCT02053350
Study Brief: Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Alanyl-glutamine Alanyl-glutamine, 44g, taken by mouth daily for 10 days. Alanyl-glutamine: Alanyl-glutamine, 44g, taken by mouth daily for 10 days 0 None 0 7 4 7 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
gastrointestinal symptoms SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (4.0) View